The mechanisms of podocyte disorders in idiopathic nephrotic syndrome (INS) are complex and remain incompletely elucidated. Abnormal regulation of NF-κB might play a key role in the pathophysiology of these podocyte diseases but it has little been investigated so far. We report here that induction of c-mip in podocytes of patients with INS is associated with a downregulation of RelA, a potent anti-apoptotic factor belonging to the NF-κB family.
Introduction
Idiopathic nephrotic syndrome (INS) defines several entities including minimal change nephrotic syndrome (MCNS), and focal and segmental glomerulosclerosis (FSGS), which are considered as prototypic podocyte diseases. 1 Podocytes are terminally differentiated cells that line the outer aspect of the glomerular basement membrane (GBM) and constitute the ultimate barrier to urinary protein loss by the formation and maintenance of the podocyte foot processes (FP) and the interposed slit diaphragm. 2 Podocyte diseases might result from genetic defects of proteins playing a key structural and/or regulatory role in the integrity of the glomerular filtration barrier. 3 Regardless of the underlying cause, the early podocyte damages are characterized by ultrastructural alterations of the slit diaphragm. Cellular injuries may progress through a reversilble stage to podocyte depletion and glomerulosclerosis, which commonly complicate the outcome of chronic glomerular diseases in INS. In acquired INS, the mechanisms preceding these changes remain to be elucidated.
The NF-κB family of transcription factors plays a central role in many cellular processes through the regulation of genes involved in immunity, inflammation, cell proliferation, differentiation and apoptosis. In mammalian cells, the NF-κB family consists of five members, NF-κB1 (p105/p50), NF-κB2 (p100/p52), RelA (p65), RelB and cRel. 4 The hallmark of NF-κB family is the presence in all members of a Rel-homology domain (RHD)
at the NH2-teminus, responsible for DNA binding, dimerization and association with the I-κB inhibitory proteins. 5 Among the NF-κB proteins, only RelA, RelB and c-Rel have a COOHterminus transactivation domain, which is lacking in p50 and p52, so that RelA, RelB and cRel homo-or heterodimers, function as transcriptional activators, whereas p50 and p52
homodimers function as repressors. 4 Although in most cases, Rel proteins act as transcriptional activators, they may repress some target genes. 6, 7 Because of its implication in many biological processes and the adverse consequences of its dysregulation, the activity of NF-κB is tightly regulated at multiple, translational and post-translational levels. The most common regulatory mechanism relies on the actions of the inhibitory I-κB proteins. 8 In resting cells, I-κB protein binds to nuclear localization site of the RHD, preventing the nuclear translocation of NF-κB protein and thereby its transcriptional activity. Upon activation, I-κB protein is phosphorylated, which allows its ubiquitination and subsequent degradation by proteasome. We recently shown that c-mip interacts with RelA and prevents its dissociation from the NFκB/IκBα complexes, resulting in the inhibition of nuclear translocation of NFκB and stabilization of IκBα.
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In human and experimental glomerular diseases, several mediators regulated by NF-κB such as cytokines and adhesion molecules have been reported to play pathogenic roles in inflammatory and proliferative glomerular diseases. 10 In non-proliferative glomerular diseases, such as minimal change disease and membranous nephropathy, characterized by heavy proteinuria, it has been suggested that the excess of proteins in the tubules and their subsequent degradation induce tubular expression of many proinflammatory genes through NF-κB activation.
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To our knowledge, the mechanisms of NF-B regulation in the podocytes are little known. We recently reported that c-mip is overproduced in the podocytes during glomerular damages and interferes with signaling pathways playing a key role in podocyte function. Whether c-mip influences NF-B activity has not been investigated.
We report here that c-mip represses in vitro and in vivo NF-κB activity by downregulating the expression of RelA. This effect was only observed in podocytes, while tubular cells displayed a contrasting increase of NF-kB activity. Moreover, c-mip increases the levels of Bax and enhances caspase 3 activity, while it reduces the Bcl-2 level, suggesting that c-mip exerts a proapoptotic function.
Materials and Methods

Patients
The diagnosis of kidney disease was carried out by renal biopsy, which was performed before the start of treatment. All patients had proteinuria above 3 g/24 h and severe hypoalbuminemia at the time of blood sampling,. MCNS and FSGS were clinically classified as idiopathic in all cases.
Control for c-mip screening includes adult patients with glomerular diseases (IgA, lupus nephritis) who exhibited a nephrotic syndrome. Normal renal samples were supplied by the hospital tissue bank (platform of biological resources, Henri Mondor hospital) from patients undergoing nephrectomy for polar kidney tumor.
Reverse transcription and real time quantitative PCR (RT-QPCR), and plasmid constructs
The expression plasmids for c-mip and RelA have been previously described. 12, 13 Mouse total RNA was prepared from glomerular fractions isolated by graded sieving, using RNeasy kit (Qiagen, France). RT-QPCR for RelA was performed using the oligonucleotides sense (5'-TGT TAC CAT CAG GGC AGA TC-3') and anti-sense (5'-CAG GGT ACT CCA TCA GCA TG-3'). The samples (2 µl of the RT reaction mixture, corresponding to 20 ng of total RNA) were amplified in a 20-µl reaction mixture containing 0. Caspase-3 activity assays.
Caspase 3 activity was monitored in a quantitative assay using a fluorogenic substrate.
Podocytes stably tranfected with c-mip or expressing empty vector (~200,000 cells) were grown on 60-mm dishes at 37°C for 96 hours. Floating cells were collected and centrifuged, and the pellet was lysed in 50 µl of lysis buffer containing 50 mM HEPES, pH 7.4, 100 mM NaCl, 1% Nonidet P-40, 1 mM EDTA (pH 8.0), 1 mM dithiothreitol, 2 µg/ml leupeptin, 2 
TUNEL (Terminal deoxynucleotidyl Transferase Biotin-dUTP Nick End Labeling)
assays.
Paraffin-embedded kidney tissue sections were dewaxed, rehydrated, then treated with proteinase K solution (10 µg/ml in 10 mM Tris-HCl, ph7,4) for 30min at room temperature.
The sections were rinsed twice with PBS and the In Situ Cell Death Detection Kit, POD (Roche Diagnostics GmbH, Germany).was used to label apoptotic cells. The sections were incubated with 50 µl TUNEL reaction mixture for 60 min at 37 o C in a humidified atmosphere in the dark. Terminal transferase was omitted for the negative control. As positive control, one section was incubated with DNase I (2000 U/ml in 50 mM Tris-HCl, ph 7,5, 10 mM MgCl2 and 1mg/ml BSA) for 10 min at RT to induce DNA strand breaks, prior the labeling procedures. The sections were rinsed 3 times with PBS, then incubated with 50 µl Converter-POD on sample, for 30min at 37 o C. The sections were rinsed 3 times with PBS, then 50 µl of DAB substrate and incubated for several minutes at room temperature. Finally, the sections were rinsed with PBS, mounted under glass coverslip and analyzed under light microscope.
Light microscopy and immunohistochemistry analysis
For light microscopy, the kidney sections from wild type and c-mip-transgenic mice were incubated for 16 hours in Dubosq Brazil, and subsequently dehydrated, paraffin- were examined by fluorescence microscopy (Zeiss, Germany) using red and green filters.
Antibodies and Western blotting
The primary antibodies used in this study included anti-RelA, anti-Tie2, anti-lamin B (Santa Cruz, Biotechnology, CA), anti-cleaved caspase 3 (Asp 75), anti-Bax, (cell signaling), antiBcl-2 (BD transduction Laboratories, USA), monoclonal anti-vimentin (Dako, Denmark), monoclonal anti-GAPDH (Abcam, Cambridge, UK), anti-actin (Sigma, Aldrich) and antinephrin (Progen, Heidelberg, Germany). The anti-c-mip polyclonal antibody has been previously described. 15 Western blotting was performed, using classical methods.
Generation of c-mip transgenic mice
The generation of c-mip transgenic mice has been previously described. 13 All experiments involving animals were conducted in accordance with French laws. . All the mice analyzed in this study were hemizygous males [Tg(+)] from the F8 to F12 generations.
Histological analysis
Morphological lesions were studied on 4 mm PAS-stained sections. Five kidney sections by mouse (n= 5 mice for each group) were analyzed. Between 20 and 30 glomeruli per kidney section were randomly selected.
Statistical Analysis
Statistical analysis of the data was performed using PRIZM 4 for Macintosh (Graphpad Software, Inc, USA). Unpaired or Paired Student t-tests were used. P value of less than 0,05 was considered significant.
Results
Expression of c-mip is associated with a downregulation of NF-κB in podocytes of patients with INS
Although the role of NF-κB in podocytes is poorly understood, it likely mediates important functions including regulation of signaling pathways and podocyte survival. 16 To investigate the possible influence of c-mip on NF-κB activity in podocytes of glomerular diseases, we studied the kidney biopsies of patients with INS. As previously reported, c-mip was clearly induced in kidney biopsies of patients with MCNS, while it was scarcely or not detected in normal human kidney. 13 The distribution pattern shows that c-mip was not confined to cytoplasmic compartment but it was also visualized in nuclei ( Figure 1A ). In contrast, we did not detect c-mip in glomeruli of IgA nephropathy or proliferative lupus nephritis.
Immunohistochemistry analysis on the same kidney specimens (five normals and twelve MCNS) using an anti-RelA antibody showed that RelA was clearly detected in normal podocytes, but it was dramatically altered in the podocytes of MCNS ( Figure 1A and 1B).
Confocal microscopy analysis of normal glomeruli (Fig 2) shows that RelA: i) colocalized partially with nephrin but not with Tie2 suggesting that its expression is restricted to podocytes; ii) did not overlap with vimentin but mostly colocalized with lamin-B, a marker of nuclear membrane. In some podocytes, Rel A was also localized within the nucleus. By contrast, in glomeruli of patients with MCNS, the abundance of RelA was lower (Fig 2) .
These results suggest that induction of c-mip in podocytes is associated with a downregulation of RelA. 
Expression of c-mip in vivo induces
C-mip displays proapoptotic properties
On the basis of the studies carried out in NF-κB-deficient mice, it is believed that NF-κB is a potent anti-apoptotic transcription factor. 17 Given our findings showing a downregulation of RelA, which is essential for NF-κB activity, we sought to determine whether c-mip influences the signaling pathways involved in apoptosis. Apoptosis is defined by morphological features including loss of adhesion, cell shrinkage and biochemical alterations such as upregulation of
Bax and caspase-3 activity. Bax belongs to Bcl-2 family proteins, which include both antiapoptotic (e.g. Bcl-2 and Bcl-xl) and pro-apoptotic (e.g. Bax, Bad) members. 18 The caspase-3 is one of the final downstream effectors of the apoptotic process and its activation is closely associated with mitochondrial dysfunction. 19 To assess whether c-mip is a proapoptotic molecule, we first transiently transfected c-mip alone in podocyte cell line and analyzed the expression level of Bax, Bcl2 and caspase 3. Overexpression of c-mip induced an upregulation of Bax and caspase 3, while Bcl2 abundance decreased when compared with empty vector-transfected cells ( Figure 4A ). On the other hand, co-transfection of RelA antagonized the proapoptotic effects of c-mip. Then, we sought whether these changes are reproducible in differentiated podocytes stably transfected with c-mip or empty vector. We studied five independent c-mip stably transfected podocyte cell lines and two control clones stably transfected with empty vector. We performed quantitative Western-blot analysis to measure the abundance of the Bcl-2 and Bax proteins that were normalized to GAPDH loading. As shown in Figure 4B , Bax was overproduced in c-mip overexpressing podocytes, so that the Bax/Bcl-2 ratio was significantly increased ( Figure 4B ). Morphological analyses showed that empty vector-transfected cells displayed small morphological changes, while cmip overexpressing podocytes exhibited severe cell shrinkage and most cells had detached.
To assess whether these morphological changes involve caspase-3 activation, we performed a caspase-3 activity assay on stable transfectant cells. Podocytes overexpressing c-mip exhibited an activation of caspase-3 in a time-dependent manner, while no significant change was detected in the empty vector-transfected podocytes ( Figure 4C ).
The relevance of these findings was analyzed in c-mip transgenic mice. In this model, mice develop after 3 months of age progressive FSGS. 13 Histological analysis ( Figure 5A ) showed that the number of glomeruli displaying FSGS lesions was increased from three (4 ± 1,5%), six (7,5 ± 2,5%) to twelve months of age (23 ± 3,5%). Western-blot analysis from glomerular extracts revealed increased Bax in c-mip Tg mice, while Bcl-2 was reduced, with a Bax/Bcl-2 ratio that was increased by 3,1 fold, as compared with wild type mice ( Figure 5B ). We then used the TUNEL assay to detect DNA fragmentation in podocytes in vivo. In wild-type mice and in 3 month-old transgenic mice, TUNEL-positive nuclei were not detectable in glomeruli. However, in transgenic mice of 6 and 12 months of age, a number of podocytes became positive for TUNEL ( Figure 6 ). Collectively, these results suggest that c-mip promotes apoptosis in vitro and in vivo.
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FSGS lesions are characterized by dysregulation of podocyte function, leading to apoptosis.
We have previously shown that c-mip abundance is increased in primary FSGS. Therefore, we investigated whether FSGS biopsy specimens exhibit active, cleaved caspase 3, a marker of cell apoptosis. Immunochemistry analysis was performed in seven FSGS biopsy specimens. Active caspase 3 was detected in all examined cases, at a variable degree, along the external side of some capillary loops, consistent with podocyte localization (Figure 7 ).
The expression was decreased or disappeared in podocyte-depleted areas corresponding to severe FSGS lesions or glomerulosclerosis. (Figure 7) . Interestingly, c-mip was increased in glomeruli in a pattern similar to that observed with active caspase 3.
Discussion
The We have previously shown that c-mip interacts through its PH domain with Fyn and PI3 kinase regulatory subunit (p85), and exerts an inhibitory role in proximal signaling. 13, 20 Cmip also binds to, and inhibits the activation of N-WASP, a major component of cytoskeleton that regulates the ARP2/3-mediated actin nucleation. In addition, we found that c-mip induces in vitro and in vivo cytoskeleton disorganization, 13 and increases the abundance of DAP kinase. 20 It has been shown that DAP kinase promotes apoptosis by disrupting integrinmediated cell adhesion, alteration of cytoskeleton and loss of extracellular matrix-dependent survival signals. 21 Alteration of the actin network induces the production of reactive oxygen species (ROS) from mitochondria, leading to apoptosis. 22 We have previously found that cmip binds RelA through its LRR-containing C-terminal domain. 9 We show here that c-mip may target RelA to proteasome-dependent degradation. Altogether, our results suggest that cmip is a multifunctional protein and may promote apoptosis through different mechanisms, including cytoskeleton alterations, upregulation of DAP kinase and downregulation of RelA.
Several studies have shown that NF-κB hyperactivation is mainly correlated with the intensity of proteinuria and is restricted in the tubules of patients with progressive kidney diseases, including glomerular diseases. [23] [24] [25] Indeed, NF-κB activity is associated with increased tubular expression of the chemokines MCP-1, RANTES, osteopontin and the profibrogenic cytokines PDGF-BB and TGFβ, 23 leading to tubular apoptosis and fibrosis. In contrast, these studies fail to detect significant hyperactivation of NF-κB in podocyte in certain forms of glomerular diseases, suggesting that this mechanism does not prevail in these cells. It has been reported that NF-κB is expressed in a few mesangial cells and tubular epithelial cells in MCNS and MN, while it is detected in podocytes of IgA nephropathy and non-IgA mesangial proliferative glomerulonephritis. 24 These data are consistent with our results because the upregulation of c-mip might account for the non-detection of NF-κB in podocytes in INS.
Conversely, in IgA nephropathy where the expression of NF-κB is found increased, c-mip was not detected in podocytes, according with previous data. 13 The downregulation of RelA in INS relapse may explain why these podocyte diseases are not associated with inflammatory processes in glomeruli. By contrast, activation of RelA in the podocytes of Par4-deficient mice is associated with severe glomerular and tubular inflammatory lesions. 26 Moreover, in pathological situations associated with sustained c-mip increase, the downregulation of NF-κB in glomeruli might represent a possible mechanism involved in podocyte apoptosis and may contribute to podocyte depletion in some podocyte diseases without early involvement of tubular and interstitial tissue injuries.
Two distinct signaling pathways are involved in the initiation of apoptosis: i) the extrinsic apoptotic pathway or receptor-linked pathway requires the binding of a ligand to a death receptor on the cell surface, such as TNF receptor; ii) the intrinsic apoptotic pathway that is mediated by mitochondrial damage and release of cytochrome C. 27 The development of the signaling cascade leading to apoptosis requires in most situations the upregulation of p53.
Despite several assays, we did not observe an upregulation of p53 in stable transfected podocytes overexpressing c-mip or in c-mip Tg mice (data not shown), which suggests that the proapoptotic function of c-mip does not require p53. Some studies have shown that the ability to trigger apoptotic pathways in the absence of p53 may result from the activation of Erk signaling. 28 However, the Erk pathway has multiple functions including pro and antiapoptotic effects of which the mechanisms are still unclear. 
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It has been shown that insulin growth factor-1 (IGF-1) protects from apoptosis induced by etoposide, an inhibitor of topoisomerase II, through a mechanism involving activation of PI3 kinase and Bad. 31 This conclusion is based on the fact that the inhibitors of PI3 kinase, Whormaninn and Ly294002, abrogate the anti-apoptotic effect of IGF1. Moreover, nephrin and VEGF inhibit apoptosis by recruiting the PI3 kinase-Akt signaling pathway. 32 Both VEGF and nephrin signaling pathways appear interconnected because mutation of nephrin, which disrupts the nephrin signaling, abrogates the anti-apoptotic effect of VEGF.
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The anti-apoptotic role of CD2AP, an adapter protein anchoring the nephrin-mediated proximal signals to actin cytoskeleton, has been evidenced by the phenotype of CD2AP-deficient mice, which develop nephrotic syndrome and renal failure caused by glomerulosclerosis. 33 In this model, proteinuria occurs in the context of accelerated apoptosis resulting from hyperactivation of p38 mitogen activated protein kinase (p38 MAPK) by TGFβ1. 34, 35 The mechanism by which CD2AP impedes the apoptotic process involves a downregulation of p38 MAPK via activation of PI3 kinase and Akt signaling. 
